Introduction
Pura is a sequence-speci®c single-stranded-DNA and RNA-binding protein originally discovered through its anity for a sequence element present at many eukaryotic DNA replication origins . Recent observations of PURA gene deletions at chromosome band 5q31 in many cases of myelogenous leukemia and myelodysplastic syndrome (Lezon-Geyda et al., 1997) have raised the possibility of a role for Pura in development of cancer. There is evidence that Pura exerts control over certain events involved in progression of the cell division cycle in higher eukaryotes. Direct evidence stems from the recent observation that intracellular levels of Pura are altered dramatically during the division cycle in CV-1 cells (Itoh et al., 1998) . Pura levels in the nucleus decline sharply in G1 just prior to the onset of S phase and remain low in early S. Levels then recover throughout late S and G2 to peak at mitosis. Pura levels remain maximal through cytokinesis and into early G1. During late S and G2, Pura is observed with Cyclin A in chromatin bodies with characteristics of replication foci. These observations have prompted the suggestion that changes in Pura levels play a functional role in cell cycle progression.
It has been reported that in transient transfection assays Pura strongly inhibits replication initiated at the JC viral (JCV) DNA replication origin in human cells (Chang et al., 1996) . In those experiments no attempt was made to relate levels of Pura expression to any eect on chromosomal DNA replication in the cell cycle. Interestingly, however, when an anti-sense Pura message was expressed, JCV DNA replication was stimulated, suggesting that the endogenous Pura exerts a negative eect on replication. Pura binds to a purinerich element which overlaps a major large T-antigen binding site at the JCV origin.
Further indication of involvement of Pura in the cell cycle is derived from details of the association of Pura with the retinoblastoma protein, Rb . Pura binds the hypophosphorylated form of Rb with an anity at least as high as that of SV40 large Tantigen such that Pura and Rb can be co-immunoprecipitated. As recently demonstrated, the co-immunoprecipitation of Pura and Rb is restricted to G1 phase of the cell cycle (Itoh et al., 1998) . The Rb-binding domain of Pura bears some homology to the counterpart domain of T-antigen, although Pura does not possess the LXCXE motif of T-antigen and certain other Rb-binding proteins. Signaling pathways leading to S phase induce the hyperphosphorylation of Rb during G1 (Chen et al., 1989; Lees et al., 1991) . Hyperphosphorylation is known to release Rb from binding to a variety of proteins, including those in the E2F family of transcription factors (Chellappan et al., 1991) , leading to subsequent activation of several genes involved in aspects of DNA replication (Chittenden et al., 1993; Helin et al., 1993; Kaelin et al., 1992; Shan et al., 1992) . Pura binds the same region of the Rb protein as does E2F, large T-antigen, the D cyclins and a variety of other proteins Ma et al., 1994) . However, at this time it is not known whether Pura binding to Rb serves any functional role in the cell cycle. In addition, it is not known whether Pura binds to other Rb-like proteins, such as p107 or p130, which may play a role in cell cycle events (Cao et al., 1992; Cobrinik et al., 1993; Ewen et al., 1991; Hannon et al., 1993; Li et al., 1993; Mayol et al., 1993) . In human cells both p107 (Devoto et al., 1992) and p130 (Hannon et al., 1993) may be found in complexes with Cyclin A and CDK2, proteins now believed to associated with Pura (Itoh et al., 1998) . In addition to its eects on DNA replication, several recent reports have now established Pura as a transcription factor (Chepenik et al., 1998; Du et al., 1997; Haas et al., 1995; Herault et al., 1992 Herault et al., , 1993 Kelm et al., 1997; Krachmarov et al., 1996; Zambrano et al., 1997) . It is quite conceivable that changes in gene expression could result from changes in Pura levels during the cell cycle.
In the present study a time-lapse video monitoring procedure is employed so that the cell cycle phase of individual, microinjected cells can be determined without the necessity of imposing cell synchrony. The results provide evidence that high levels of Pura block the cell cycle at speci®c points in G2 and, with less eciency in G1; and that Pura does not arrest ongoing DNA replication. Arrest induced at the dierent cell cycle points is accompanied by distinct morphological changes.
Results

Pura arrests the cell division cycle of NIH3T3 cells
Experiments were initially designed to determine if microinjected Pura could alter cell cycle progression. For this analysis concentrated GST-Pura protein was microinjected into NIH3T3 cells synchronized by serum deprivation (0.5% serum for 48 h). Greater than 95% of the cells in such cultures were blocked in cell cycle progression but re-entered S phase beginning 12 ± 15 h after serum addition. Pura was injected into all the cells localized within a circular area drawn on the back of a coverslip at 8 h after serum addition, when most of the cells would have been in late G1 phase. Beginning immediately following the injection and continuing 35 ± 45 h thereafter the injected and surrounding uninjected cells were followed in time lapse microscopy. Careful analysis of the resulting time lapse movie made it possible to follow the fate of individual cells. As a control, separate but similar analyses were performed following injection of control GST protein prepared and concentrated exactly as with the GST-Pura. When the data from combined injections with either Pura or control GST were compared it was apparent (consistent with many previous injections with numerous other proteins) that GST did not inhibit cell cycle progression, while approximately 80% of the Pura-injected cells were blocked in cell cycle progression. This was apparent from the results of a single experiment (Table 1) and from the combined results of three separate experiments (Figure 1 ). Of those Pura-injected cells which did divide, there was a slight delay in the timing of mitosis (Table 1 ). There was no signi®cant dierence in time of mitosis or number of dividing cells between GSTinjected cells and uninjected cells (Table 1) . Interestingly, many of the cells injected with Pura protein experience a rapid cell death, accounting for the cells listed as dying in Table 1 . This phenomenon, as described in detail later in this report, involves primarily cells injected in G1 and is characterized by a rounding up of the cells and dramatic expulsion of cell debris into the surrounding medium. This entire process requires less than 20 min in most cases. While it is not presently known whether this process is, in fact, apoptosis, the phenomena are characterized by a common sequence of events. This rapid cell death process was observed within a single cell cycle following injection so that none of the cells experiencing this phenomenon underwent prior mitosis. Table 1 indicates that Pura-injected cells which escape programmed death also undergo cell cycle arrest.
To determine where in the cell cycle the Purainjected cells had been blocked, an analysis similar to that described above was performed, except that the quiescent cells were injected with Pura prior to serum addition, and the DNA content of individual injected or uninjected cells was determined 30 h later. For this analysis the cells were followed in time lapse to identify and track individual injected and uninjected cells, after which, following treatment with RNase, the culture was ®xed and stained with propidium iodide. Fluorescent intensity levels of individual cells were then determined with a microscopic photomultiplier to determine DNA content. Within the 30 h of this analysis, 86% of the uninjected cells, but only 26% of the injected cells, had passed through mitosis. Despite the fact that over 95% of the cells contained 2 N (G1 phase) levels of DNA at the time of injection, as is characteristic of these quiescent NIH3T3 cells, more than 50% of the non-dividing, injected cells contained 4 N (G2 phase) DNA levels (Figure 2 , top) after 30 h. The proportion of cells with 2 N and 4 N levels of DNA observed in cycling, uninjected cells within the same culture is presented for comparison These results are from a single, typical experiment. Non-dividing cells are those which remained viable but did not pass through mitosis during the analysis. Time of mitosis is calculated beginning at the time of serum stimulation (Figure 2, bottom) . It is apparent that while 30% of the cells were blocked with a G1 DNA content, many of the injected cells had passed through S phase prior to experiencing the Pura-mediated cell cycle block at G2/M.
Pura blocks the cell cycle in G1 or G2 phases of proliferating cells with distinct morphological consequences
In order to determine more precisely the points in the cell cycle at which Pura-injected cells were arrested, microinjection of Pura was performed into asynchronously proliferating cultures of NIH3T3 cells. The Pura injection was positioned between two separate, sequential time lapse analyses. Thus the cells to be injected were followed for 24 h prior to the injection of Pura, and then a second movie was made of the injected cells immediately following injection and for the next 2 ± 3 days. The pre-injection movie was used to determine how long prior to injection an individual cell had passed through mitosis. Extensive independent analyses have established that S phase begins in these NIH3T3 cells approximately 5 h following mitosis in an asynchronously proliferating culture. S phase continues for approximately 7 ± 8 h, and G2 phase begins at 13 ± 14 h following mitosis. The cells display a generation time of approximately 17 h. Thus, cells injected within the ®rst 5 h following mitosis would almost certainly be in G1 phase at the time of injection, while cells injected between 5 and 12 h following mitosis would most likely be in S phase at the time of the injection. In this way cells in all phases of the cell cycle were analysed simultaneously without any manipulations required for cell synchronization.
From the post-injection movie it was clear that a high proportion of the Pura-injected cells were blocked from passing through cell division, as was observed for the synchronized cells. After 30 h or more following injection the injected cells took on a characteristic appearance by occupying a larger than normal surface area, and by excluding most uninjected cells from the area of injection ( Since the cells in asynchronous culture were injected in all phases of the cell cycle, it was possible that individual cells could have been blocked at dierent cell cycle points. To test this possibility the DNA content of individual, injected cells was determined after ®xation, propidium iodide staining and quantitation with a microscopic photomultiplier as described above. For comparison the DNA contents of neighboring uninjected cells were also determined. Most of the asynchronous cells injected with Pura were blocked with a 4 N DNA content (Figure 4) . It was clear from analysis performed for Figure 4 and from the photograph of Figure 3 that the large cells arrested at G2/M by Pura are actually arrested in G2 since no prophase or mitotic ®gures can be seen either upon propidium staining or direct visualization. In Figure 4 cells blocked with a 2 N DNA content comprised 14% of the total number. Note that this analysis excludes cells that died soon after injection and that many of the dying cells may also have been blocked in G1. Note also that a minor but signi®cant number of cells were arrested with a DNA content 44 N. For comparison, more than 75% of the uninjected cells possessed a 2 N DNA content.
In separate experiments a mutant Pura protein (Pura1-215) was also injected as a control into asynchronously proliferating NIH3T3 cells and analysed as above. This mutant includes two of three DNA-binding repeats of Pura, and it binds to DNA , but it lacks Rb-binding and glutamine-rich domains . The eect of the control protein upon the cell cycle progression was determined by measuring the length of the cell cycle in which injection was performed (the time between the last mitosis prior to injection of the control protein and the ®rst mitosis following Figure 2 DNA content of cells released from serum starvation and arrested in the cell cycle by microinjected Pura. Quiescent NIH3T3 cells received injections of Pura prior to serum addition and were followed in time lapse thereafter. Thirty h after injection the cells were ®xed, stained with propidium iodide and their DNA content quantitated with a microscopic photomultiplier. Seventy individual injected cells were individually analysed, of which 61 failed to divide. The relative DNA contents of these non-dividing cells is presented (top panel); with the DNA contents of neighboring, uninjected cells presented for comparison (bottom panel). In separate injections of GST control protein most injected cells cycled normally and expressed primarily 2N (G1 phase) DNA levels as seen here with the uninjected cells injection). It was found that the mutant protein had no signi®cant eect upon the length of the cell cycle during which the injection took place (data not shown). Also, the total number of mutant protein-injected cells which passed through mitosis during the 30 h of the post-injection time lapse analysis was essentially the same as this number for uninjected cells. As expected, since the injected cells cycled normally, the distribution of DNA in the mutant-injected cells was altered little from that of the uninjected neighboring cells, with most cells expressing a 2 N DNA content.
DNA content of arrested cells reveals an ecient G2 block by injected Pura
We next considered whether the fate of Pura-injected cells was aected in any way by their cell cycle position at the time of injection. For this purpose the DNA content of asynchronously proliferating cells, the cell cycle progression of which had been blocked by Pura injection, was plotted vs the time following mitosis at which the injection took place ( Figure 5 ). In this way it was possible to correlate the cellular consequences of Pura injection with the cell cycle stage in which injection took place. The results indicate that while a proportion of the cells injected soon after mitosis (during G1 phase) were blocked with a G1 DNA content, many of these cells become blocked with a G2 phase DNA content. This would indicate that Pura has the ability to block cells in at least two stages of the cell cycle. The G1/S phase block was apparently incomplete since approximately 50% of G1 injected cells passed through S phase prior to becoming arrested in G2. On the other hand, the G2 block was much more ecient since approximately 80% of cells in S phase at the time of injection were blocked at G2 phase ( Figure 5 ). There were few cells blocked mid-way through S phase, although it is possible that some cells with an apparent 4 N DNA content might have been blocked in late S phase. The existence of cells injected apparently during S phase but blocked with G1 DNA content is most likely explained by the observation that a minor population of NIH3T3 cells possess a G1 period that is longer than normal (Stacey, submitted for publication). Those cells, injected between 5 and 12 h following mitosis, which were blocked in G1 were most likely cells which had a longer-than-normal G1 period. This does not aect our results since the total number of such cells seen in Figure 5 is less than 3% of the total injected cells. On the other hand, the presence of cells with greater than G2 DNA levels in Figure 5 is not so easily explained. A careful analysis of these cells with unusually high DNA levels revealed that they were mononucleate with a phase-contrast nuclear appearance indistinguishable from other cells. It is notable that such cells appeared to cover a larger surface area than did other Pura-inhibited cells. For example, see in Figure 3 cells #41, 13 and 22, which had 44 N DNA contents. In comparison, cells with a 2 N DNA content, #29, 47 and 105, were smaller than normal and were originally circled to identify their positions.
Rapid cell death induced by Pura injection in G1 phase
As observed initially following injection of Pura into synchronized G1 phase cells, a number of the asynchronous, injected cells likewise displayed a sudden cell death phenotype. The appearance of the cell death was quite similar for the two types of determinations. The timing of this cell death was not con®ned to any period following injection, but generally occurred within 40 h. To determine if this phenotype was in any way in¯uenced by the cell cycle stage at which injection occurred, the time between mitosis and microinjection was determined for those cells which died. For the purpose of demonstration, cells injected within 5 h of mitosis were considered to be in G1 phase at the time of injection; cells injected between 5 and 12 h of mitosis were considered to be in S phase; and cells injected between 12 ± 16 h of mitosis were considered to be in G2 phase. It is clear from Figure 6 that while some cells injected at any point in the cell cycle could undergo the rapid cell death, the likelihood of this phenotype was greatly increased in cells within G1 phase at the time of injection. In G1-injected cells death was as likely as blockage of cell cycle progression. On the other hand, the likelihood that a cell in S or G2 phases would die was approximately one fourth as likely as with a G1 phase cell. In comparison, almost all the cells injected with control GST protein remained viable and proliferated normally following injection (Table 1) . Thus, it is clear that the eects of injection of Pura are highly dependent upon the cell cycle time of injection. These observations might help explain the importance of the intermolecular interactions between Pura and Rb or other G1 phase cell cycle regulatory proteins. 
Discussion
Because of its interaction with a variety of proteins involved in cell cycle progression, we tested the possibility that the cellular levels of Pura might be important for passage through the cell cycle. Pura injected into serum-starved and released NIH3T3 cells eciently blocked passage through mitosis whether injected prior to serum addition or 8 h thereafter, when the cells would have been in G1 phase. While cell cycle progression was blocked to a limited extent near the G1/S phase boundary in these synchronized cells, a more ecient blockage was observed at G2/M. Microinjection was performed using GST-Pura fusion proteins. GST-Pura has previously been shown to possess the activity of the Pura protein. It binds to the PUR recognition element Johnson et al., 1995; Krachmarov et al., 1996) , binds to the retinoblastoma protein , and interacts with JCV large T-antigen at the origin of DNA replication (Chang et al., 1996) . Injections of control GST protein had no observable eects, compared to uninjected cells, upon cell cycle progression or DNA content.
In experiments performed with asynchronous cultures, using a time lapse video technique that allows determination of cell cycle time of injection, it was possible to analyse cells of a single culture in all phases of the cell cycle without any requirement for cell synchrony. Consistent with the results obtained in serum deprived cultures, 480% of the Pura-injected, asynchronous cells were inhibited from passing through mitosis. After several days the surviving Pura-injected cells increased dramatically in size to cover nearly fourfold more surface area than uninjected or control protein-injected cells. DNA analyses indicated that virtually all of these large cells were blocked with a G2 DNA content. Approximately 12% of non-cycling cells were inhibited with G1 DNA levels. This may represent a minimum for the number of cells arrested in G1 since about 9% of all injected cells underwent a rapid death phenomenon, and most of these were injected in G1. Neither an inactive Pura mutant protein nor GST control protein altered cell cycle progression or DNA content of asynchronously injected cells. Moreover, extensive past studies with other GST-fusion proteins, notably GST-E2F1, had eects upon NIH3T3 cell cycle progression opposite those observed here with GST-Pura (Dobrowolski et al., 1994) . In separate studies to be presented elsewhere Pura was transduced into CV-1 cells as a fusion protein with a peptide derived from the HIV-1 Tat protein. As in the present study, cell cycle arrest was coupled with morphological eects.
Microinjected Pura blocks cell cycle progression most eciently at the G2/M boundary. It has recently been reported that Pura is associated in late S and G2 with newly replicated DNA and cyclin A (Itoh et al., 1998) . Cyclin A is known to be at high levels in G2 and to be degraded during mitosis (Pines and Hunter, 1991a,b) . In contrast to Cyclin A, however, Pura levels remain high through mitosis (Itoh et al., 1998) . Thus inhibition of entry into mitosis may not be due simply to high Pura levels. The arrest at G2/M could conceivably be due to a`squelching'-like eect in which excess Pura could sequester proteins, possibly including Cyclin A, from their normal functions. In addition, while it is clear that Pura does not block ongoing DNA synthesis (see Figure 5) , it might interfere with complete DNA replication or another checkpoint late in the cell cycle (Cox and Lane, 1995; Levine, 1997; Morgan and Kastan, 1997; Nurse, 1997) to account for this inhibition. Clearly, Pura also has the ability to block the G1/S transition, although with less eciency than the G2/M block, since 12 ± 22% of arrested cells are blocked in G1, the remainder progressing on to be arrested at G2/M. This result might indicate that the observed decline in Pura levels prior to entry into S phase (Itoh et al., 1998) is important for an aspect of entry into S phase. The likelihood of a programmed cell death in response to Pura injection was greatly increased when Pura was introduced in G1 phase. These G1 eects emphasize the potential importance of the interaction between Pura and proteins which function during the G1/S transition, such as Rb (Itoh et al., 1998; Ma et al., 1994) . It is worth noting when considering a connection between Rb and Pura that marrow samples from a high percentage of patients with acute myeloblastic leukemia (AML) or myelodysplastic syndrome (MDS), a leukemic precancerous condition, display deletions in the PURA gene (LezonGeyda et al., 1997) , located at 5q31 . Rb mutations are rarely seen in either AML or MDS.
A small but signi®cant number of Pura-injected cells were arrested at G2/M with DNA levels greater than 4 N. While the numbers of such cells were low, two factors suggest that this observation might be important. Firstly, the likelihood of this occurrence increased in cells injected with Pura late in the cell cycle. Secondly, the eventual DNA content in such cells was relatively uniform. This observation will require more study but could possibly result from the interaction of Pura with factors involved in controlling re-replication of DNA without passage through mitosis. Interestingly, 14-3-3s protein induces a p53-related G2 checkpoint block which is followed by rereplication of DNA, as is also seen here in some Purainjected NIH3T3 cells (Hermeking et al., 1997) .
Finally, those Pura-injected cells which were blocked with 4 N DNA levels tended to increase in size over time to occupy a larger than normal surface area. It remains to be determined whether this growth in apparent size represents an increase in cell volume or an increase in¯attening to a large area. This growth to large size may be likened to the eect of reintroduction of Rb into SAOS2, Rb 7/7 cells. Rb causes a G1 block accompanied by characteristic cell swelling (Qin et al., 1995; Templeton et al., 1991) . However, in the case of Pura it is primarily G2-arrested cells which become large. A G2 arrest has not previously been associated with cell swelling.
Materials and methods
Cell culture
NIH3T3 cells were cultured in D-MEM supplemented with 10% calf serum, penicillin and streptomycin. Prior to video analysis cells were transferred to a moist environmental chamber on a microscope stage with a constantly-renewed 5% CO 2 atmosphere at 378C. Measurements of cell numbers indicated that the cells proliferated at the same rate in the chamber used for video analysis as in the standard incubator. The line of cells used has been cultured and stored frozen in this laboratory (DW Stacey) over several years so that cell cycle kinetics have been repeatedly measured and standardized. Cells (5 ± 20610 74 ) were plated on a coverslip in a 35 mm dish in preparation for video analysis. Cells were selected for analysis when they covered approximately 30% of the surface area of the coverslip.
For studies of cells in synchronous populations, NIH3T3 cells were arrested by serum starvation for 48 h (0.5% serumcontaining medium). Cells were then washed and released into medium containing 10% fetal bovine serum. Microinjection was performed prior to serum stimulation of quiescent cultures, or at varying times thereafter. Timing of mitosis was monitored by video analysis.
Time lapse video photography
Digital images were obtained with a CCD camera attached to a frame capture board controlled by the NIH Image program. Individual frames of 6406480 pixels were captured every 5 ± 15 min. Up to 310 individual frames were captured in a single stack, which was then replayed by the Image program at varying speeds in the forward or backward direction to create a movie for analysis. Images of cells were obtained with phase contrast optics and a 46 objective to allow analysis of the largest possible area of the coverslip. The area of the coverslip to be analysed was marked with a circle on the back of the coverslip using a diamond object marker (Leitz). This allowed realignment of the area of analysis and identi®cation of individual cells following propidium staining. Proteins to be studied were microinjected into all the cells, and only the cells, within the designated circular area. In this way it was possible to follow the analysis beginning immediately following injection to determine which cells had arisen from originally injected cells. The injected proteins were all anity puri®ed to homogeneity, as determined by SDS polyacrylamide gel electrophoresis. The GST fusion proteins were puri®ed on glutathione-agarose columns, and the antibodies were puri®ed on protein A-agarose columns as described previously . The proteins injected, each at 4 mg/ml, were: GST-Pura, the potential dominant-negative GST-Pura deletion mutant, Pura1-215 (Krachmarov et al., 1996) , control GST, anti-Pura mouse monoclonal antibody 9C12 and irrelevant control mouse monoclonal antibody to GST.
Measurement of DNA content of individual cells
Cells were ®xed with ethanol immediately upon termination of the video collection to ensure that the cell positions were the same in the ®xed sample as in the last frame of the video. Cells were then treated with RNase A (Sigma; 1.0 mg/ml), and DNA was stained with propidium iodide (2.0 mg/ml). Fluorescence from individual cells was measured with a Leitz microscopic photomultiplier. When data from two dierent days employing photomultiplier readings were combined, normalized photomultiplier values were determined in order to eliminate variations due to handling and window analysis size. Therefore, after discarding the highest 5% and lowest 5% of absolute readings, the values for each given experiment were assigned a scale of 0 ± 100 for the lowest and highest readings. Values for DNA content for dierent experiments were consistent as evident by the near coincidence of values obtained on dierent days for 2 N and 4 N, representing DNA content of G1 and G2/M cells, respectively. Values for 2 N and 4 N, represented by readings of approximately 10 ± 20 and 50 ± 70, respectively, were determined from the DNA contents of normal, noninjected, cycling cells.
Analysis of cell cycle parameters of individual cells
The new methodology employed here allows the analysis of kinetics of the cell division cycle of individual cells, and the microinjection of such cells at speci®c points in the cycle, without the necessity of imposing any synchronization. Video monitoring of the asynchronous cells was begun 24 h prior to microinjection. Cells were microinjected without regard to their position in the cell cycle although cells in mitosis were avoided. The stack of individual frames (the movie) of the cells prior to microinjection was then followed in a reverse direction beginning at the last frame taken to determine how long prior to injection each individual cell had passed through mitosis (the age of the cells). Since the timing of the cell cycle for the NIH3T3 cells employed has been wellcharacterized under these conditions (manuscript in review), the approximate cell cycle time at microinjection could thus be retroactively ascertained. Protein-injected cells were identi®ed as those arising from cells within the circular area at the beginning of the movie. After the video collection, DNA content of the individual cells, either injected or uninjected, was determined as described following RNase treatment and staining with propidium iodide. One series of experiments was performed on NIH3T3 cells synchronized by release from serum starvation. In that series microinjection was performed in G1 phase. Unless otherwise indicated, each microinjection experiment was performed four times, with at least 150 cells injected each time. Data from two separate, representative video collections, from identically-treated cells, were combined for each of the ®gures presented. The surface areas of individual cells were determined using the NIH Image program by outlining the perimeter of individual injected and uninjected cells.
